Doctors: Patents keep HIV drugs too pricy to use
July 02, 2013  22:22
Doctors Without Borders warned today that rising intellectual property rights are blocking the generic production of newer drugs to treat HIV and are keeping them out of reach for developing countries. 

The medical aid group said at an international AIDS meeting here that prices of older drugs long used to treat patients have fallen sharply as India and other countries make generics.

But newer drugs that are more effective against the AIDS virus are too expensive, costing up to 15 times more. 

"It's good news that the price of key HIV drugs continues to fall as more generic companies compete for the market, but the newer medicines are still priced far too high," said Jennifer Cohn, medical director for Doctors Without Borders' access campaign. 

"We need the newer treatments for people that have exhausted all other options, but patents keep them priced beyond reach."

Patients can be treated with a combination of three or four older drugs, but those who develop resistance to them need the expensive newer medicines. 
« Back to LIVE

TOP STORIES